AdBio partners has 2 portfolio companies on record at Recent Funding. It led 1 of the 2 rounds it joined. Its most recent investment on record is Agomab Therapeutics's $74M Series B+ round in March 2021, alongside V-Bio Ventures, Redmile Group, Pontifax and 4 others. By category, its portfolio leans toward Health and bio (2). It has co-invested with OMNES Capital, Boehringer Ingelheim Venture Fund and Pontifax, most often OMNES Capital (2 rounds).

What AdBio partners invests in

• Health and bio · 2 · 100%

How AdBio partners invests

Share is of the 2 rounds on Recent Funding that name AdBio partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

AdBio partners portfolio companies

• AAgomab Therapeutics$74MSeries B+ · Mar 2021
• TTenpoint Therapeuticsbacker

Most frequent co-investors

• OOMNES Capital2 shared rounds · last Mar 10, 2021
• BBoehringer Ingelheim Venture Fund2 shared rounds · last Mar 10, 2021
• PPontifax2 shared rounds · last Mar 10, 2021
• VV-Bio Ventures2 shared rounds · last Mar 10, 2021
• AAndera Partners1 shared round · last Mar 10, 2021
• CCormorant Asset Management1 shared round · last Mar 10, 2021
• RRedmile Group1 shared round · last Mar 10, 2021

Similar investors

• CCalm/Storm VC2 companies · 2 deals in 12 mo
• HHuatai Zijin Investment2 companies · 2 deals in 12 mo
• IIIMA Ventures2 companies · 2 deals in 12 mo
• SSound Bioventures2 companies · 2 deals in 12 mo
• TTenmile2 companies · 2 deals in 12 mo
• TThe FSE Group2 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists AdBio partners, which is a subset of its real portfolio. API: /api/v1/investors/adbio-partners (get a free API key). More: the most active VC firms and new venture capital funds.